This inventor holds 6 USPTO granted patents. Top assignees: Millennium Pharmaceuticals Limited, Children's Medical Center Corporation, The Brigham and Women's Hospital, Inc.. Active years: 1995-2008.
Company Filing History:
3 out of 854 
2 out of 1,072 
2 out of 1,424 
Years Active: 1995-2008
Title: The Innovative Contributions of Norma P Gerard
Introduction
Norma P Gerard is a distinguished inventor based in Dover, MA (US). She has made significant contributions to the field of biochemistry, particularly in the area of chemokine receptors. With a total of 6 patents to her name, her work has implications for therapeutic applications in various diseases.
Latest Patents
Among her latest patents, Gerard has developed isolated and/or recombinant C-C Chemokine Receptor 3 (CKR-3, CCR3) proteins. This invention relates to the production of proteins or polypeptides that are crucial for understanding leukocyte function. Another notable patent involves antibodies to C-C chemokine Receptor 3 Protein, which includes isolated and/or recombinant nucleic acids encoding the receptor protein. These innovations are essential for identifying ligands, inhibitors, or promoters of receptor function, providing new approaches to treat inflammatory and autoimmune diseases.
Career Highlights
Throughout her career, Norma P Gerard has worked with notable companies, including Millennium Pharmaceuticals Limited. Her research has focused on the therapeutic potential of chemokine receptors, making her a key figure in the field of immunology.
Collaborations
Gerard has collaborated with esteemed colleagues such as Craig J Gerard and Charles R Mackay, contributing to the advancement of knowledge in her area of expertise.
Conclusion
Norma P Gerard's innovative work in the field of chemokine receptors has paved the way for new therapeutic strategies. Her contributions continue to impact research and development in immunology and related fields.